Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 500,000 shares at $15.33 ($7.8M) on 2022-11-21, disclosed to the SEC on 2022-11-22.
Open-market sale of $7.8M CPRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.62 | 350,000 | $5.5M | 70.4% |
| 2 | $15.33 | 150,000 | $2.3M | 29.6% |
| Total | $15.53 avg | 500,000 | $7.8M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |